Flow Cytometry (Extracellular): HEK-293F cells transiently transfected with human VEGFA were stained with VEGFA Monoclonal Antibody (CSB0117) (green) or isotype control antibody (gray), followed by AlexaFluor 647-conjugated anti-Mouse IgG secondary antibody. HEK-293F cells transiently transfected with an empty control vector were also stained with VEGFA Monoclonal Antibody (CSB0117) (blue).

VEGFA MAb - CSB0117

Catalog #: CSB0117
Applications: FC   IF   ICC   ELISA   WB  
Isotype: Mouse IgG2a
Reactivity: Human (others untested)
Concentration: 1 mg/ml
Size: 100 µg
Technical Data Sheet
Safety Data Sheet
$475.00
Adding to cart… The item has been added
  • Description
Description
Specificity ProfileMore Information

The specificity of VEGFA Monoclonal Antibody (CSB0117) was tested on the Membrane Proteome Array™ and shown to be specific for human VEGFA.

The Membrane Proteome Array™ contains 6,000 different human membrane proteins, each expressed in unfixed human cells to ensure native conformation and post-translational modifications. The Membrane Proteome Array™ represents the industry standard for determining the binding specificity of antibodies and other protein ligands.

ApplicationConditionsRecommended Concentration
Flow Cytometry, ExtracellularLive, Unpermeabilized1 µg/ml
HEK-293F cells transiently transfected with human VEGFA were stained with VEGFA Monoclonal Antibody (CSB0117) (green) or isotype control antibody (gray), followed by AlexaFluor 647-conjugated anti-Mouse IgG secondary antibody. HEK-293F cells transiently transfected with an empty control vector were also stained with VEGFA Monoclonal Antibody (CSB0117) (blue).
ApplicationConditionsRecommended Concentration
Immunofluorescence, ExtracellularFixed 4% paraformaldehyde1 µg/ml
(A) COS-7 cells transiently transfected with human VEGFA were stained with VEGFA Monoclonal Antibody (CSB0117) followed by AlexaFluor 647 anti-Mouse IgG secondary antibody (red) and DAPI (blue). (B) COS-7 cells transiently transfected with an empty control vector stained with VEGFA Monoclonal Antibody. (C) Isotype control: COS-7 cells transfected with human VEGFA and stained with control MAb.
ApplicationConditionsRecommended Concentration
Immunofluorescence, IntracellularFixed 4% paraformaldehyde, Permeabilized 0.1% Triton X-1001 µg/ml
(A) COS-7 cells transiently transfected with human VEGFA were permeabilized and stained with VEGFA Monoclonal Antibody (CSB0117) followed by AlexaFluor 647 anti-Mouse IgG secondary antibody (red) and DAPI (blue). (B) COS-7 cells transiently transfected with an empty control vector stained with VEGFA Monoclonal Antibody. (C) Isotype control: COS-7 cells transfected with human VEGFA and stained with control MAb.

CSB VeRSaMAbs:
We produce and validate all our monoclonal antibodies in-house so that you can confidently choose the right antibody for your assay. All antibodies are VALIDATED for common applications, RECOMBINANT for batch-to-batch consistency, and SPECIFIC in binding to only your target.

TargetVEGFA
Target AliasesVPF, VEGF, MVCD1
IsotypeMouse IgG2a
Membrane Proteome SpecificityMonospecific for 6,000 membrane proteins tested
Species ReactivityHuman (others untested)
Fc ModificationsC-terminal Avitag, disabled Fc-gamma receptor binding
SourceRecombinant CHO expression; purified by Protein A chromatography
FormulationEndotoxin Free PBS pH 7.4, sterile-filtered
Concentration1 mg/ml

Stable for 12 months from date of receipt when stored at 4°C. Avoid repeated freeze-thaw cycles.

VEGF-A is a member of the PDGF/VEGF growth factor family. Specifically, VEGF-A is a disulfide-linked homodimer that binds heparin. VEGF-A is a secreted protein involved in endothelial cell proliferation and migration, angiogenesis, and vasculogenesis. Increased expression is associated with SARS-CoV-2 and POEMS syndrome as well as many tumors, and allelic variants are associated with microvascular complications of diabetes 1 and atherosclerosis. (NCBI Gene: 7422, UniProtKB/Swiss-Prot: P15692). Other names: VPF, VEGF, MVCD1

Circle Icon